Eye mounted device for controlling focusing disorders

US10802298B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10802298-B2
Application numberUS-201715639514-A
CountryUS
Kind codeB2
Filing dateJun 30, 2017
Priority dateJul 15, 2016
Publication dateOct 13, 2020
Grant dateOct 13, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An eye mounted display presents defocused images to patients to affect their eyeball development and control focusing disorders such as myopia or hyperopia. For example, images may be projected with peripheral myopic defocus in order to control myopia. Images may be projected with peripheral hyperopic defocus in order to control hyperopia.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of controlling eye focusing disorders in a patient, the method comprising: diagnosing an eye focusing disorder for the patient; and having the patient wear an eye mounted treatment device comprising: a contact lens; and a first group of one or more femtoprojectors mounted in the contact lens, the first group projecting light into the patient's eye, wherein said light is defocused to form images in front of or behind the patient's retina, and the defocus is selected based on stimulating eye growth to control the diagnosed eye focusing disorder. 2. The method of claim 1 where the patient is less than 18 years of age. 3. The method of claim 1 where the diagnosed eye focusing disorder is myopia and the first group projects light into the patient's eye with peripheral myopic defocus to form images in front of a peripheral area of the patient's retina. 4. The method of claim 1 where the diagnosed eye focusing disorder is hyperopia and the first group projects light into the patient's eye with peripheral hyperopic defocus to form images behind a peripheral area of the patient's retina. 5. The method of claim 1 where the diagnosed eye focusing disorder is accommodative lag and the first group projects light into the patient's eye with central myopic defocus to form images in front of a central area of the patient's retina. 6. The method of claim 1 further comprising: measuring a shape of the patient's eye; and selecting from a plurality of eye mounted treatment devices with different focus positions for the first group, based on the focus position of the first group relative to the shape of the patient's eye. 7. The method of claim 1 wherein the eye mounted treatment device further comprises a second group of one or more femtoprojectors mounted in the contact lens, the second group projecting light into the patient's eye, said light focused on the patient's retina. 8. The method of claim 2 wherein the second group projects light to a center area of the patient's retina, and the first group projects light to a peripheral area of the patient's retina. 9. The method of claim 2 wherein both the first and second group project light to a center area of the patient's retina. 10. The method of claim 1 wherein the first group also projects light with enhanced brightness in a blue region of a visible spectrum. 11. The method of claim 1 wherein the first group projects light into the patient's eye with defocus of not more than three diopters.

Assignees

Inventors

Classifications

  • G02C7/04Primary

    Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00) · CPC title

  • Myopia progression prevention · CPC title

  • for determining the shape or measuring the curvature of the cornea · CPC title

  • provided with illuminating means (A61B3/117, A61B3/14 take precedence) · CPC title

  • Exercisers for training the stereoscopic view · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10802298B2 cover?
An eye mounted display presents defocused images to patients to affect their eyeball development and control focusing disorders such as myopia or hyperopia. For example, images may be projected with peripheral myopic defocus in order to control myopia. Images may be projected with peripheral hyperopic defocus in order to control hyperopia.
Who is the assignee on this patent?
Spy Eye Llc, Tectus Corp
What technology area does this patent fall under?
Primary CPC classification G02C7/04. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).